The FTC Should Keep Its Hands Off Innovative Biopharma Mergers
A crackdown on biopharma mergers led by the FTC could undermine future accomplishments, harming the American economy and patents.
New Antitrust Bills — Anti-Consumer, Anti-Enterprise, and Anti-Innovation
The proposals toss antitrust’s proper concern to the side and focus exclusively on the market’s biggest actors.
The FTC’s Repeal of Enforcement Guidance Is Bad News for Business
Without the proper guardrails guiding the agency’s hand, there will likely be major losses for the competitive health of the American economy.
The Internet Doesn’t Need Heavy-Handed Regulation
A Facebook VP’s proposal to regulate the Internet would undermine competition, innovation, and free speech.
Waiving IP Protection for COVID Vaccines Is Anti-innovation and Anti–Public Health
Patent rights were key to the unprecedentedly rapid development and rollout of COVID-19 vaccines.
Antitrust Should Stay Focused on Consumer Welfare
Antitrust attacks aimed at ‘cutting monopoly platforms down to size’ harm consumers.